Essays & Commentaries
- Rethinking USPTO Applicant Diversity, IPWatchdog (Jan. 31, 2021)
- The Lackluster Revolution of CBM Review, Fed Circuit Blog (Sept. 15, 2020)
- Silicon Valley’s APA Challenge to PTAB Discretion, PatentlyO (Sept. 2, 2020)
- Immigration, Patents, and Judicial Review of Agency Action, Yale Journal on Regulation, Notice & Comment Blog (Mar. 25, 2020)
- Joinder and the One-Year Time Bar in Inter Partes Review, PatentlyO (Mar. 20, 2020)
- Appellate Standing, Biosimilars, and the Federal Circuit, PatentlyO (Mar. 11, 2019), with Jonathan Stroud
- Managing the PTAB's Legacy of Partial Institution, PatentlyO (Sept. 24, 2018)
- First Steps After SAS Institute, PatentlyO (April 27, 2018)
- Mapping the Patent Office Intervenor Power, PatentlyO (February 5, 2018)
- Antitrust-Style Analysis in Patent Law, The Antitrust Attorney Blog (January 30, 2018)
- Shenanigans, Time Bars, and Federal Circuit Oversight, PatentlyO (January 10, 2018)
- Section 101 as a Shortcut for Other Patentability Requirements, PatentlyO (August 7, 2017)
- Court-Agency Allocations of Power and the Limits of Cuozzo, PatentlyO (May 5, 2017)
- Precedent and Process in the Patent Trial and Appeal Board, PatentlyO (May 10, 2016)
- Ariosa v. Sequenom: In Search of Yes After a Decade of No, Nat'l L. Rev. (Dec. 4, 2015)
- Commil v. Cisco and the Tort of Patent Infringement, Written Description (Dec. 9, 2014)
- Cognitive Economy and the Trespass Fallacy: A Response to Professor Mossoff, 65 Fla. L. Rev. Forum 38 (2014)
- The Growing Public Domain in Medicine, 15 Colum. Sci. & Tech. L. Rev. 293 (2014)
- What Patent Attorney Fee Awards Really Look Like, 63 Duke L.J. Online 15 (2014)
- Protecting the Public from Itself: The Unconstitutional ‘Say No to Drug Ads’ Act, 25 WLF Legal Backgrounder, No. 7 (2010)